Amanote Research
Register
Sign In
46. Gene Therapy of Congenital Erythropoietic Porphyria Using Genetically Modified Induced Pluripotent Stem Cells
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35850-6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
548 Prenatal Diagnosis of Congenital Erythropoietic Etic Porphyria
Pediatric Research
Child Health
Pediatrics
Perinatology
From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing
Annual Review of Genetics
Genetics
Induced Pluripotent Stem Cells
Cell Transplantation
Transplantation
Biomedical Engineering
Cell Biology
Metabolic Correction of Congenital Erythropoietic Porphyria With iPSCs Free of Reprogramming Factors
American Journal of Human Genetics
Genetics
Cell Therapy for Parkinson’s Disease With Induced Pluripotent Stem Cells
Clinical Neurology
Neurology
Immunogenicity of Induced Pluripotent Stem Cells
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
An Ex Vivo Gene Therapy Approach to Treat Muscular Dystrophy Using Inducible Pluripotent Stem Cells
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Maintaining Embryonic Stem Cells and Induced Pluripotent Stem Cells
Human Testis–Derived Pluripotent Cells and Induced Pluripotent Stem Cells
